02 8011 4217, 0416 974 651  info at scenar.com.au

Experience of Using SCENAR-therapy in Treating Some Pain Syndromes

Experience of Using SCENAR-therapy in Treating Some Pain Syndromes

Publication: Collection of Articles “SCENAR-Therapy and SCENAR-Expertise”. Issue 5, 1999. p. 48-51.
Authors: T.A. Volyanik

Translated from Russian to English Language by Kate Zhilina
May 2006, Petrovskaya 99, Taganrog 347900, http://scenar.com.ru

SCENAR is an effective device for the treatment of many diseases. This effectiveness is provided by the main specificity of SCENAR action.
1. High-amplitude (but non-damaging) action;
2. Absence (substantial diminishing) of the process of adaptation. Due to return biological connection, each impulse is different from the previous. As a result, SCENAR action activates considerable amounts of neuro-fibres, including thin C-fibres, which makes this treatment different from other types of electrotherapy [1,2].

Chemical intermediates (neuro-mediators) in these fibres are made from numerous groups of neuro-peptides, which, when combined with other humor factors, provide any possible biologic function.

The anti-pain effect from SCENAR comes about because of stimulation of the production of not only endorphins, but also other neuro-peptides (neuro-tensine, cholecysto-kinin, etc.) which regulate nociceptive and anti-nociceptive endogenous systems [3,4].

Anti-pain effects from SCENAR action was used for treating patients with neuralgia of the trigeminal nerve (NTN) and with Herpes Zoster.

During 1,5 years 6 patients with NTN were treated, 5 men and one women, aged 48 -70. Duration of the disease was from 1,5 -5 years. SCENAR action was applied on the point of outlet of branches of the trigeminal nerve, segmental pain, and collar zones in continuous mode, with the frequency of impulses from 50 -70Hz. Most of the patients had their sessions daily.

After 10 sessions one patient had a full remission, without taking finlipsine, for 6 months, another had a remission on the background of low dosages of finlipsine. One patient did not have a complete remission. For two patients the treatment was not effective (one of them received only 5 sessions). There were no neuralgic foci symptoms on examination of the patients. Two patients had CT of the brain (normal according to their age).

For understanding the results of SCENAR therapy we should consider the idea of etiological pathogenesis of NTN.

It is established that NTN appears, due to a neuro-vascular conflict [5,6] between the artery and root of the trigeminal nerve (NTN), which is pulled over the pulsing artery. The pulsating beat of the artery, from the force of its action, has a nociceptive effect on the nerve. With age, nociceptive influence increases due to progression of atheroscleriosis, which leads to an increase of density of the vessel and physiological age de-myelinezation of the fibres of the peripheral nerves. By this we can explain why mainly old people suffer with NTN [7]. When a quantity of the non-myelin fibres become predominate, the activity of the second neurone will increase, which in turn transfers pain impulses further along the chain of the neurones to the brain cortex, and then severe suffering from NTN emerges.

To SCENAR therapists, we would like to point out, that in some cases, neuro-vascular conflict is due to a tumour in the area of pons-cerebellum angle or aneurysm, which has been subjected to operative treatment, especially in cancerous tumours. Considering that the effect from SCENAR therapy on NTN is temporal, all patients must be examined by a neurologist and if necessary by CT, in order to diagnose early the cancerous processes and to have timely treatment.
There were 13 patients with Herpes Zoster in the second group. In all cases, SCENAR therapy was conducted on the pain zones, rash zones and symmetric areas of the skin on the opposite side, in order to give a reflective influence on the pathologic focus. Time of the action was 10-15 minutes before pain disappeared. Most of the patients had the session’s daily, some of them two times a day.

There were 12 patients with an acute stage of Herpes Zoster, – 5 males, 7 females – aged from 31 to 70 years. 5 patients had herpes rash at the zone of enervation of the trigeminal nerve, 5 on the level of thoracic segments, 2 on the level of lumbar segments. 8 out of 12 were using limited drug therapy. Analgesic effect was observed straight away after the first SCENAR action and lasted for 5 -8 hours; the pain then resumed, but was less acute. After 3 -5 sessions, 8 patients experienced a complete cessation of pain, while the others had considerable improvement. Catamnesis are known for 8 patients from 3 months to 1,5 years – the pain syndrome did not resume.

Four women of ages 68 to 82 had treatment concerning post herpes neuralgia, which lasted from 1 to 2 years. Three patients suffered with pain at the level of thoracic segments. For this period of time, different types of physiotherapy were used without a considerable effect. After 10 sessions of SCENAR therapy, the pain had stopped completely and for 1-1,5 years did not resume.

One patient aged 82 suffered with acute and frequent pain around the chest at the level of thoracic segments for 1,5 years. During this period she received a few courses of IRT, different type of physiotherapy, and one course of roentgenotherapy, without any effect. The patient was given 3 courses of SCENAR therapy in combination with IRT for 10-16 sessions a course with a break for 3-4 weeks. To clarify the location of zones for the treatment, the reflexo-diagnostic set “RISTA -EPD” was used. The effect from the treatment was quick, mainly during the therapy. Catamnesis – pain was still there, but not as intensive.

Generally speaking, SCENAR therapy provides, in the majority of cases, a quick, positive effect in the treatment of Herpes Zoster, especially in the acute stages. The therapy allows a considerable reduction in the intake of medicines, increases the defensive characteristics of the body and also helps the patients to get rid of pain in situations when other ways of treatment are less effective.